(Q40117313)

17 September 2017

Impact of Sustained Virologic Response with Direct-Acting Antiviral Treatment on Mortality in Patients with Advanced Liver Disease (English)

1 reference

17 September 2017

0 references

Lisa I Backus

1

1 reference

17 September 2017

Pamela S Belperio

series ordinal

2

1 reference

17 September 2017

Troy A Shahoumian

series ordinal

3

1 reference

17 September 2017

Larry A Mole

series ordinal

4

1 reference

17 September 2017

language of work or name

English

0 references

publication date

27 July 2017

1 reference

17 September 2017

1 reference

Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.

17 September 2017

1 reference

7 January 2021

A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C.

1 reference

7 January 2021

All-cause, liver-related, and non-liver-related mortality among HCV-infected individuals in the general US population

1 reference

7 January 2021

Successful anti-viral treatment improves survival of patients with advanced liver disease due to chronic hepatitis C.

1 reference

7 January 2021

Long-Term Treatment Outcomes of Patients Infected With Hepatitis C Virus: A Systematic Review and Meta-analysis of the Survival Benefit of Achieving a Sustained Virological Response

1 reference

7 January 2021

Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications

1 reference

7 January 2021

Management of the patient with SVR.

1 reference

7 January 2021

Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: A 5-year follow-up of 150 patients

1 reference

7 January 2021

Outcome of sustained virological responders with histologically advanced chronic hepatitis C.

1 reference

7 January 2021

Long-term outcome after antiviral therapy of patients with hepatitis C virus infection and decompensated cirrhosis

1 reference

7 January 2021

Progressive fibrosis significantly correlates with hepatocellular carcinoma in patients with a sustained virological response

1 reference

7 January 2021

Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C

1 reference

7 January 2021

Transformation of hepatitis C antiviral treatment in a national healthcare system following the introduction of direct antiviral agents.

1 reference

7 January 2021

Clinical Case Registries: simultaneous local and national disease registries for population quality management

1 reference

7 January 2021

A new equation to estimate glomerular filtration rate

1 reference

7 January 2021

Systemic inflammation predicts all-cause mortality: a glasgow inflammation outcome study.

1 reference

7 January 2021

Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly

1 reference

7 January 2021

What is the impact of chronic systemic inflammation such as rheumatoid arthritis on mortality following cancer?

1 reference

7 January 2021

The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease

1 reference

7 January 2021

Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy

1 reference

7 January 2021

Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals

1 reference

7 January 2021

Unexpected high incidence of hepatocellular carcinoma in cirrhotic patients with sustained virologic response following interferon-free direct-acting antiviral treatment

1 reference

7 January 2021

Direct acting antiviral therapy and tumor recurrence after liver transplantation for hepatitis C-associated hepatocellular carcinoma.

1 reference

7 January 2021

Improved survival of patients with hepatocellular carcinoma and compensated hepatitis C virus-related cirrhosis who attained sustained virological response.

1 reference

7 January 2021

Lack of evidence of an effect of direct-acting antivirals on the recurrence of hepatocellular carcinoma: Data from three ANRS cohorts

1 reference

7 January 2021

Is the risk of neoplastic recurrence increased after prescribing direct-acting antivirals for HCV patients whose HCC was previously cured?

1 reference

7 January 2021

Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.29408

1 reference

17 September 2017

1 reference